Azole derivatives of 1,4-benzothiazine as antifungal agents. 1998

R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
Istituto di Chimica e Tecnologia del Farmaco, Università di Perugia, Italy.

A series of azole derivatives of 1,4-benzothiazine 7-14 was synthesized and evaluated for the in vitro and in vivo activity against Candida albicans. Secondary alcohol 10 and its ether derivative 13 showed very good efficacy against systemic candidiasis in a murine experimental model.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001393 Azoles Five membered rings containing a NITROGEN atom. Azole
D013047 Specific Pathogen-Free Organisms Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free. Pathogen-Free Organisms,Specific Pathogen Free,Organism, Pathogen-Free,Organism, Specific Pathogen-Free,Organisms, Pathogen-Free,Organisms, Specific Pathogen-Free,Pathogen Free Organisms,Pathogen Free, Specific,Pathogen Frees, Specific,Pathogen-Free Organism,Pathogen-Free Organism, Specific,Pathogen-Free Organisms, Specific,Specific Pathogen Free Organisms,Specific Pathogen-Free Organism
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
January 2023, Current medicinal chemistry,
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
March 1969, Journal of medicinal chemistry,
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
March 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
August 2003, Journal of medicinal chemistry,
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
June 2023, Computational biology and chemistry,
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
January 1999, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology,
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
August 2011, Journal of medicinal chemistry,
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
March 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
February 2005, Drugs of today (Barcelona, Spain : 1998),
R Fringuelli, and F Schiaffella, and F Bistoni, and L Pitzurra, and A Vecchiarelli
January 2018, Journal of medicinal chemistry,
Copied contents to your clipboard!